The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

A method of obtaining ketones from a fermentation process may include collecting an off-gas and a fermented broth from a fermenter, transferring the off-gas from the fermenter to a ketone recuperation module and the fermented broth to a fluid separating module, and isolating the ketones from both the off-gas and the fermented broth. The off-gas and the fermented broth may both comprise a ketone.

A method of obtaining ketones from a fermentation process may include collecting an off-gas and a fermented broth from a fermenter, transferring the off-gas from the fermenter to a ketone recuperation module and the fermented broth to a fluid separating module, and isolating the ketones from both the off-gas and the fermented broth. The off-gas and the fermented broth may both comprise a ketone.

A method of obtaining ketones from a fermentation process may include collecting an off-gas and a fermented broth from a fermenter, transferring the off-gas from the fermenter to a ketone recuperation module and the fermented broth to a fluid separating module, and isolating the ketones from both the off-gas and the fermented broth. The off-gas and the fermented broth may both comprise a ketone.

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

A method of obtaining ketones from a fermentation process may include collecting an off-gas and a fermented broth from a fermenter, transferring the off-gas from the fermenter to a ketone recuperation module and the fermented broth to a fluid separating module, and isolating the ketones from both the off-gas and the fermented broth. The off-gas and the fermented broth may both comprise a ketone

A method of obtaining ketones from a fermentation process may include collecting an off-gas and a fermented broth from a fermenter, transferring the off-gas from the fermenter to a ketone recuperation module and the fermented broth to a fluid separating module, and isolating the ketones from both the off-gas and the fermented broth. The off-gas and the fermented broth may both comprise a ketone